비교리스트

 카트 문의
시장보고서
상품코드
1279673

세계의 유방 재건 시장(2023-2030년)

Global Breast Reconstruction Market - 2023-2030
발행일: | 리서치사: DataM Intelligence | 페이지 정보: 영문 195 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

시장 개요

유방 재건 세계 시장은 2022년 5억 7,433만 달러에 달할 것으로 예상되며, 2030년에는 9억 3,430만 달러에 달할 것으로 예상됩니다. 이 시장은 예측 기간(2023-2030년) 동안 6.4%의 CAGR을 보일 것으로 예상됩니다.

유방 재건은 유방 절제술 후 유방을 정상에 가깝게 복원하기 위해 여러 가지 성형외과적 기법을 사용합니다. 임플란트 재건과 플랩 재건은 유방 재건의 두 가지 주요 유형입니다. 보형물 재건에서는 유방 보형물을 사용하여 새로운 유방 언덕을 만듭니다. 플랩(또는 자가) 재건은 신체의 다른 부위에서 채취 한 환자 자신의 조직을 사용하여 새로운 유방을 만듭니다.

시장 역학

유방 재건 치료에 대한 인식이 높아지면서 유방 재건 시장의 성장을 촉진하고 있습니다

인지도 향상은 독립 기관과 시장 진입 기업의 행동에 기인합니다. 예를 들어, 2021년 10 월 22 일, 임플란트 제조업체 인 AbbVie는 재건의 가능성을 소개하는 캠페인을 전개합니다. 이 유방 보형물 제조업체는 새로운 'Power of You' 캠페인을 통해 이를 바꾸고자 합니다. 이 캠페인은 환자들의 용기와 내면의 불굴의 정신을 기리고 유방 재건 옵션을 알리는 것입니다. 이 캠페인은 노브랜드이지만 이 회사의 유방 재건 제품에는 조직 확장기, 임플란트 전달 슬리브, 나트렐(Natrelle) 브랜드 임플란트가 포함되어 있습니다.

또한 유방재건술에 대한 인식을 높이기 위해 Tata Memorial Centre는 'Reconstruction and Cancer Care . 2022년 2월 17일에 "Enhancing Quality Living with and Beyond Cancer"라는 제목의 컨퍼런스를 개최했습니다. 앞서 언급한 요인으로 인해 유방 재건 시장은 예측 기간 동안 선두를 차지할 것으로 예상됩니다.

3D 프린터별 임플란트 개발로 상업적 확대가 기대됩니다

3D 프린터를 이용한 임플란트 개발은 상업적 확장을 위한 상당한 전망을 제시할 수 있습니다. 예를 들어, 2023년 4월 6일에는 CollPlant와 Stratasys가 유방 보형물을 바이오프린팅할 예정입니다. Stratasys는 CollPlant와의 협력을 통해 바이오 프린트를 사용하여 의료를 변화시키고 유방 보형물 및 복원 치료를 받는 환자의 삶을 개선할 수 있는 큰 잠재력을 가지고 있습니다.

바이오프린팅 기술 개발을 위해 콜플랜트와 스트라타시스는 공동 개발 및 상용화 계약을 체결했습니다. 이번 제휴를 통해 스트라타시스의 P3 기술 기반 바이오 프린터와 콜플랜트의 rhCollagen 기반 바이오 잉크를 결합하여 P3로 알려진 Programmable PhotoPolymerization은 유용한 최종 용도 부품의 대량 생산을 위한 디지털 광처리 기술의 개발입니다. 유용한 최종 용도 부품의 대량 생산을 위한 디지털 광처리(DLP) 기술 개발입니다.

COVID-19 영향 분석

시장은 COVID-19 사태로 인해 일시적으로 영향을 받았지만, 대부분 초기 단계에 영향을 받았습니다. 제한과 봉쇄로 인해 진행 중이거나 예정된 수술이 연기되거나 취소되어 유방 보형물 시장의 확장을 방해했습니다. 그러나 미국에서 COVID-19가 여성들 사이에서 유행했을 때, 가슴성형과 보형물을 포함한 외모에 대한 관심과 인식이 높아졌습니다. 그 결과, 시장은 COVID-19 팬데믹의 영향을 회복하고 발전할 것으로 예상됩니다.

러시아-우크라이나 전쟁 영향 분석

러시아-우크라이나 전쟁은 이 지역의 낮은 보급률과 주요 시장 참여자가 없기 때문에 세계 유방 재건 시장에 미치는 영향은 미미할 것으로 추정됩니다. 그러나 원자재, 시험 제품 및 장치의 수입 및 수출의 영향은 예측 기간 동안 세계 유방 재건 시장에 거의 영향을 미치지 않을 것으로 예상됩니다.

인공지능의 영향력 분석

인공지능은 유방 재건 및 암 수술을 위한 세계 최초의 공유 의사결정 도구인 Breast Advocate 앱 덕분에 세계 유방 재건 시장에 긍정적인 영향을 미칠 것으로 예상됩니다. 이 앱은 유방암 진단을 받았거나 유방암에 걸릴 위험이 있는 사람이라면 누구나 수술과 관련된 선택에 대해 발언권을 가질 수 있는 무료 앱입니다. 이 앱은 유방암 의사와 환자 활동가들이 공동으로 개발했습니다.

목차

제1장 조사 방법과 범위

  • 조사 방법
  • 조사 목적 및 조사 범위

제2장 정의와 개요

제3장 주요 요약

  • 제품 유형별
  • 형태별
  • 배치별
  • 최종사용자별
  • 지역별

제4장 시장 역학

  • 영향요인
    • 성장 촉진요인
      • 세계의 유방암 이환율 증가
      • 유방재건 치료에 대한 인식 확산
    • 성장 억제요인
      • 유방 외과수술 비용이 높다
    • 기회
      • 3D 프린트 임플란트 도입
    • 영향 분석

제5장 산업 분석

  • Porter's Five Forces 분석
  • 공급망 분석
  • 미충족 수요
  • 규제 분석

제6장 COVID-19 분석

  • COVID-19 분석
    • COVID-19 도입전 시나리오
    • 현재 COVID-19 시나리오
    • COVID-19 이후 또는 향후 시나리오
  • COVID-19 중에서의 가격·역학
  • 수급 스펙트럼
  • 팬데믹 동안 시장과 관련된 정부 이니셔티브
  • 제조업체 각사의 전략적 대처
  • 결론

제7장 러시아·우크라이나 전쟁 분석

제8장 인공지능의 영향 분석

제9장 제품 유형별

  • 임플란트
  • 조직 확장기
  • 세포 진피 매트릭스

제10장 형태별

  • 라운드 형태
  • 해부학적 형태

제11장 배치별

  • 이중 평면 삽입
  • 선하 삽입
  • 근막하 삽입

제12장 최종사용자별

  • 병원
  • 외래 수술 센터
  • 기타

제13장 지역별

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 러시아
    • 기타 유럽
  • 남미
    • 브라질
    • 아르헨티나
    • 기타 남미
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카

제14장 경쟁 상황

  • 경쟁 시나리오
  • 시장 점유율 분석
  • M&A(인수합병) 분석

제15장 기업 개요

  • Allergan Plc
    • 기업 개요
    • 제품 유형별 포트폴리오와 내용
    • 재무 개요
    • 주요 발전 상황
  • Sientra, Inc
  • IDEAL IMPLANT INCORPORATED
  • Johnson & Johnson
  • Establishment Labs S.A.
  • GC Aesthetics
  • Groupe Sebbin SAS
  • Ideal Implant Incorporated
  • Laboratoires Arion
  • Mentor Worldwide LLC.

제16장 부록

ksm 23.06.05

Market Overview

The global breast reconstruction market reached US$ 574.33 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 934.30 million by 2030. The market is expected to exhibit a CAGR of 6.4% during the forecast period (2023-2030).

Breast reconstruction uses several plastic surgical techniques to return a breast to a state that is very close to normal after a mastectomy. Implant-based reconstruction and flap reconstruction are the two main types of breast reconstruction. Breast implants are used in implant reconstruction to create a new breast mound. Flap (or autologous) reconstruction creates a new breast using the patient's own tissue from another area of the body.

Market Dynamics

Growing Awareness About Breast Reconstruction Treatment is Driving the Breast Reconstruction Market Growth.

The increase in awareness can be attributed to actions made by independent bodies and market participants. For instance, on October 22, 2021, AbbVie, an implant manufacturer, develops a campaign to showcase reconstruction possibilities. With its new "Power of You" campaign, the breast implant manufacturer hopes to change that. The initiative honors patients' bravery and inner fortitude while educating them on their options for breast reconstruction. Although the campaign is unbranded, the company's breast reconstruction products include tissue expanders, implant delivery sleeves, and Natrelle-branded implants.

Additionally, to raise awareness of breast reconstruction, Tata Memorial Centre organized a conference titled Reconstruction and Cancer Care: Enhancing Quality Living with and Beyond Cancer on February 17, 2022. As a result of the aforementioned factors, the breast reconstruction market is anticipated to lead throughout the forecast period.

The Development of 3D-printed Implants May Present Considerable Prospects for Commercial Expansion.

The development of 3D-printed implants may present considerable prospects for commercial expansion. For instance, on April 06, 2023, Breast implants will be bioprinted by CollPlant and Stratasys. The company has a significant chance to use bioprinting to alter healthcare and better the lives of patients undergoing breast augmentation or repair treatments thanks to its cooperation with CollPlant.

To advance the development of bioprinting technology, CollPlant, and Stratasys inked a combined development and commercialization agreement. The collaboration will pair Stratasys' P3 technology-based bioprinter with CollPlant's rhCollagen-based bio-inks. Programmable PhotoPolymerization, also known as P3, is a development of digital light processing (DLP) technology intended for the bulk manufacturing of useful end-use components.

COVID-19 Impact Analysis

The market was temporarily impacted by the COVID-19 pandemic, mostly during the pandemic's early stages. The ongoing and scheduled surgical procedures were postponed or canceled as a result of the limitations and lockout, which hampered the expansion of the breast implant market. However, during the COVID-19 pandemic among women in the United States, interest and growing awareness regarding physical appearance, including breast augmentation and implants, increased. As a result, the market is anticipated to rebound from the COVID-19 pandemic's effects and develop.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine is estimated to have a minimal impact on the global breast reconstruction market owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global Breast reconstruction market in the forecast period.

Artificial Intelligence Impact Analysis

Artificial intelligence is anticipated to impact the global breast reconstruction market positively owing to the Breast Advocate app being the first shared decision-making tool for breast reconstruction and cancer surgery in the world. It is a free app that gives anybody with a breast cancer diagnosis or at risk of getting breast cancer a voice in the choices made about their surgery. It was co-created by breast cancer doctors and patient activists.

Segment Analysis

The global breast reconstruction market is segmented based on product type, shape, placement, end-user, and region.

The Round Shape Segment is Estimated to Hold a Majority of the Breast Reconstruction Market Share During the Forecast Period.

The round shape holds about 56% of the total breast reconstruction market in the forecast period owing to the acceptance of new products by different permitting bodies. The dominance can be due to the increase in product announcements, the FDA's regular updates on the safety of breast implants, and the execution of several clinical investigations.

For instance, GC Aesthetics will introduce the PERLE, a new generation of round silicone breast implants, in May 2021. In order to ensure that patients undergoing breast implant surgery have enough information, the U.S. FDA amended its safety guidelines for breast implants in October 2021 and prohibited the sales and distribution of breast implants. Therefore, round-shaped breast implants are anticipated to experience significant growth as a result of the aforementioned factors.

Geographical Analysis

Asia Pacific is Estimated to Hold the Second-largest Share of the Global Breast Reconstruction Market During the Forecast Period.

The Asia Pacific region holds the second largest share of the global breast reconstruction market accounting for approximately 33% in the forecast period. The rise in awareness of breast reconstruction surgery and the fast-rising breast cancer population are both responsible for the growth.

For instance, the NCBI data revealed that there were approximately 303,600 new instances of breast cancer and 70,400 fatalities from the disease in China. Furthermore, according to a similar source, the incidence rate and mortality rate in China are predicted to rise by 2030 due to changing demographics and risks. More than 76.5% of women preferred breast reconstruction following mastectomy, according to research by a similar source.

Competitive Landscape

The major global players in the market include: Allergan Plc, Sientra, Inc, IDEAL IMPLANT INCORPORATED, Johnson & Johnson, Establishment Labs S.A., GC Aesthetics, Groupe Sebbin SAS, Ideal Implant Incorporated, Laboratoires Arion, and Mentor Worldwide LLC, among others.

Why Purchase the Report?

  • To visualize the global breast reconstruction market segmentation based on product type, shape, placement, end user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of breast reconstruction market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global Breast reconstruction market report would provide approximately 69 tables, 66 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Shape
  • 3.3. Snippet by Placement
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The increasing prevalence of breast cancer worldwide is expected to drive market growth.
      • 4.1.1.2. Growing Awareness about breast reconstruction treatment
    • 4.1.2. Restraints
      • 4.1.2.1. The high cost of breast surgical procedures is expected to hamper the market growth
    • 4.1.3. Opportunity
      • 4.1.3.1. The introduction of 3D-printed implants may present significant advantages market expansion opportunities
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Impact Analysis

9. By Product Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.1.2. Market Attractiveness Index, By Product Type
  • 9.2. Implants
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Tissue Expander
  • 9.4. Acellular Dermal Matrix

10. By Shape

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
    • 10.1.2. Market Attractiveness Index, By Shape
  • 10.2. Round Shape
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Anatomical Shape

11. By Placement

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 11.1.2. Market Attractiveness Index, By Placement
  • 11.2. Dual Plane Insertion
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Subglandular Insertion
  • 11.4. Submuscular Insertion

12. By End User

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.1.2. Market Attractiveness Index, By End User
  • 12.2. Hospitals
    • 12.2.1. Introduction
    • 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3. Ambulatory Surgical Centers
  • 12.4. Others

13. By Region

  • 13.1. Introduction
    • 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 13.1.2. Market Attractiveness Index, By Region
  • 13.2. North America
    • 13.2.1. Introduction
    • 13.2.2. Key Region-Specific Dynamics
    • 13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
    • 13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.2.7.1. The U.S.
      • 13.2.7.2. Canada
      • 13.2.7.3. Mexico
  • 13.3. Europe
    • 13.3.1. Introduction
    • 13.3.2. Key Region-Specific Dynamics
    • 13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
    • 13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.3.7.1. Germany
      • 13.3.7.2. The U.K.
      • 13.3.7.3. France
      • 13.3.7.4. Italy
      • 13.3.7.5. Russia
      • 13.3.7.6. Rest of Europe
  • 13.4. South America
    • 13.4.1. Introduction
    • 13.4.2. Key Region-Specific Dynamics
    • 13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
    • 13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.4.7.1. Brazil
      • 13.4.7.2. Argentina
      • 13.4.7.3. Rest of South America
  • 13.5. Asia-Pacific
    • 13.5.1. Introduction
    • 13.5.2. Key Region-Specific Dynamics
    • 13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
    • 13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.5.7.1. China
      • 13.5.7.2. India
      • 13.5.7.3. Japan
      • 13.5.7.4. Australia
      • 13.5.7.5. Rest of Asia-Pacific
  • 13.6. Middle East and Africa
    • 13.6.1. Introduction
    • 13.6.2. Key Region-Specific Dynamics
    • 13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
    • 13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

14. Competitive Landscape

  • 14.1. Competitive Scenario
  • 14.2. Market Share Analysis
  • 14.3. Mergers and Acquisitions Analysis

15. Company Profiles

  • 15.1. Allergan Plc
    • 15.1.1. Company Overview
    • 15.1.2. Product Type Portfolio and Description
    • 15.1.3. Financial Overview
    • 15.1.4. Key Developments
  • 15.2. Sientra, Inc
  • 15.3. IDEAL IMPLANT INCORPORATED
  • 15.4. Johnson & Johnson
  • 15.5. Establishment Labs S.A.
  • 15.6. GC Aesthetics
  • 15.7. Groupe Sebbin SAS
  • 15.8. Ideal Implant Incorporated
  • 15.9. Laboratoires Arion
  • 15.10. Mentor Worldwide LLC.

LIST NOT EXHAUSTIVE

16. Appendix

  • 16.1. About Us and Services
  • 16.2. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제